Retinoic Acid Embryopathy
- 3 October 1985
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 313 (14) , 837-841
- https://doi.org/10.1056/nejm198510033131401
Abstract
Retinoic acid, an analogue of vitamin A, is known to be teratogenic in laboratory animals and has recently been implicated in a few clinical case reports. To study the human teratogenicity of this agent, we investigated 154 human pregnancies with fetal exposure to isotretinoin, a retinoid prescribed for severe recalcitrant cystic acne. The outcomes were 95 elective abortions, 26 infants without major malformations, 12 spontaneous abortions, and 21 malformed infants. A subset of 36 of the 154 pregnancies was observed prospectively. The outcomes in this cohort were 8 spontaneous abortions, 23 normal infants, and 5 malformed infants. Exposure to isotretinoin was associated with an unusually high relative risk for a group of selected major malformations (relative risk = 25.6; 95 per cent confidence interval, 11.4 to 57.5).This publication has 26 references indexed in Scilit:
- Fetal hydrocephalus and ear anomalies associated with maternal use of isotretinoinThe Journal of Pediatrics, 1984
- Craniofacial features of isotretinoin embryopathyThe Journal of Pediatrics, 1984
- The Isotretinoin Teratogen SyndromePublished by American Medical Association (AMA) ,1984
- ISOTRETINOIN TERATOGENICITYThe Lancet, 1984
- Vitamin A and Retinoids in Health and DiseaseNew England Journal of Medicine, 1984
- ISOTRETINOIN DYSMORPHIC SYNDROMEThe Lancet, 1984
- TERATOGENICITY OF ISOTRETINOINThe Lancet, 1983
- VITAMIN A AND RETINOIDS: FROM NUTRITION TO PHARMACOTHERAPY IN DERMATOLOGY AND ONCOLOGYThe Lancet, 1983
- Congenital Malformations Surveillance: Two American SystemsInternational Journal of Epidemiology, 1981
- THALIDOMIDE AND CONGENITAL ABNORMALITIESThe Lancet, 1961